Dr. Aisha Batool, MD

Dr. Batool practices at Ascension Columbia St. Mary's Hospital - Milwaukee Campus in Milwaukee, Wisconsin, part of Ascension Health Alliance.

Dr. Batool's NPI, 1356698229, was assigned on August 10, 2012. Dr. Batool holds Wisconsin license 71472.

Dr. Batool's primary practice is Ascension Columbia St. Mary's Hospital - Milwaukee Campus, at 2323 N Lake Dr, Milwaukee, WI 53211 in Milwaukee County. The practice phone is (414) 585-1374.

Dr. Batool's primary practice is Ascension Columbia St. Mary's Hospital - Milwaukee Campus in Milwaukee, Wisconsin, part of Ascension Health Alliance. Dr. Batool is also affiliated with Froedtert Hospital. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians. Dmand AI also links Dr. Batool to 2 more medical groups, 1 behavioral health center, 1 clinical lab and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Batool practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Batool's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Batool is licensed in Wisconsin.

CMS data shows 48 Medicare services from Dr. Batool across 2 procedure codes in 2024, for 60 Medicare patients. Medicare paid $2,729 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 60 Medicare patients who saw Dr. Batool in 2024. The largest group is 65 to 74, with 22 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 30% are also on Medicaid. Their average risk score is 5.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Batool's median patient age at 66, with 51% women.

In 2024, Dr. Batool wrote 47 Medicare Part D claims for 25 patients. 89% of them were for generic drugs. CMS names the drug for 39 of them, across 3 drugs with 11 or more claims each, at $978 in total drug cost. In 2021, CMS named 74 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Batool for performance year 2024, reported as part of a group. Dr. Batool accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Batool as offering telehealth.

Dmand AI links 12 papers to Dr. Batool, published from 2017 to 2024. 2018 was the busiest year, with 3. The most frequent topics are Point-of-Care Systems. Dr. Batool has published most often in Cureus. Dr. Batool's most frequent co-authors are Shahzad C. Chaudhry, MD, Abhilash Koratala, MD and Aisha Siraj, MD.

CMS Open Payments shows 30 general payments to Dr. Batool from 8 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $201.